APA (7th ed.) Citation

Gelbard, M., Goldstein, I., Hellstrom, W. J. G., McMahon, C. G., Smith, T., Tursi, J., . . . Carson, 3. (2013). Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. The Journal of urology, 190(1), 199. https://doi.org/10.1016/j.juro.2013.01.087

Chicago Style (17th ed.) Citation

Gelbard, Martin, Irwin Goldstein, Wayne J G. Hellstrom, Chris G. McMahon, Ted Smith, James Tursi, Nigel Jones, Gregory J. Kaufman, and 3rd Carson. "Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-blind, Randomized, Placebo Controlled Phase 3 Studies." The Journal of Urology 190, no. 1 (2013): 199. https://doi.org/10.1016/j.juro.2013.01.087.

MLA (9th ed.) Citation

Gelbard, Martin, et al. "Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-blind, Randomized, Placebo Controlled Phase 3 Studies." The Journal of Urology, vol. 190, no. 1, 2013, p. 199, https://doi.org/10.1016/j.juro.2013.01.087.